Fair Isaac Corporation (FICO) trades at $725.33 on November 3, 2026. The shares are up 5.1% in five days but still 60.7% below their 52-week high and under the 40-week average. A downgrade on pricing concerns and earnings due November 4 leave the balance of evidence leaning negative for the next two to six weeks, with high conviction. The bounce has stalled below $750, and a daily close under $700 would open the road to the 52-week low at $592.47.
Why it matters
The most recent event is a negative one. In its roundup of the week's analyst calls, published November 1, 2026, Investing.com listed Fair Isaac among five major downgrades, citing pricing concerns. The other four names in that list were hit by earnings misses or strategic shocks. FICO's was a judgement on the franchise's pricing power, which is the core of the investment case, not a one-quarter stumble.
The stock had already been through a violent year, so much of the bad news was in the price. FICO rose almost 14% in the week ended October 16, 2026, when, according to CNBC, stocks outside the artificial intelligence trade beat the market by one of the widest margins in nearly three years. The rally peaked with a close of $823.27 on October 22 and has since given back 11.9%. Even so, the shares are up about 10% over one month, against a loss of roughly 30% over six months and 57% for the year to date.
The latest five days are the odd part. The stock gained 5.1% while the S&P 500 fell 2.1% and the technology sector ETF (XLK) fell 7.1%. That puts FICO about 12 points ahead of its sector, so neither the market nor the sector explains the move. The news flow does not explain it either, and the downgrade points the other way. The bounce came on volume 64% below the 20-day average, which suggests thin buying and not a rush of conviction.
The debate is about whether the franchise is being eroded or merely repriced. BMO's October 20 note, as Investing.com headlined it, reiterated its rating on the argument that the FICO score is being displaced only to a limited degree. The other side is the pricing-concern downgrade: the score may stay dominant, but the price charged for it may be reaching its limit. Analysts overall remain constructive. Nineteen cover the stock, the consensus is buy, and the mean price target of $897.05 sits 19.1% above the share price. The range from $490 to $1,230.97 shows how little agreement there is on what the business is worth.
What the evidence says
On the long term, the thesis is broken for now. The stock sits 60.7% below its 52-week high of $1,844.98 and below both its 10-week and 40-week averages. The 50-day average at $854.02 lies far under the 200-day at $1,114.57. This is a stock in a long markdown that has bounced 22.4% off its low of $592.47, not one basing for a new advance. The bounce has not yet changed the structure.
For the next two to six weeks the balance of evidence leans negative, and the conviction is high, at 3 of 4 points. The daily trend runs in the same direction as the weekly downtrend. Over 50 days FICO has lagged the S&P 500 by 13.6 points and lagged XLK by 9.0 points. That second figure matters because the sector itself has been weak: the stock is losing ground even against a falling group.
The strongest case against this reading is the recent strength. FICO beat its sector by 12.2 points in five days, gained about 10% in a month, and the Street still rates it a buy with a target 19.1% above the price. The RSI of 51 shows the stock is neither oversold nor stretched, so there is no exhausted selling to lean on. Earnings arrive tomorrow and can move the shares either way. This does not tip the balance because the rally has been turned back under $750, the price remains well below the 50-day average, and the buying came on light volume. It is also why conviction is not at the maximum.
Levels that matter
The structure holds below $750, a round number where sellers have shown up on earlier rallies. Above it, $800 and the 50-day average at $854.02 are the next obstacles. The trend would end only on a weekly close above $1,014.5, a swing zone from the earlier decline. That is a long way from $725.33, which is why a bounce alone does not repair the weekly picture.
The breakout level on the downside is a daily close below $700. From there $650 is the next round-number support, and the 52-week low at $592.47 is the target. A move would be wrong above $759.77, which is $750 plus a quarter of the 14-day average true range of $39.08. Measured from $700, the reward-to-risk is 1.8 to 1. That does not reach the 3 to 1 that makes a breakout worth the risk. It would take a target well below $592.47, or a trigger much closer to the stop, roughly near the current price rather than $700.
What would change the picture
A weekly close above $1,014.5 would end the downtrend in the structure. The non-price fact that would most likely cause it is evidence that FICO's pricing power is intact: earnings and guidance showing that the concerns behind the downgrade were overdone, with the BMO argument about limited displacement borne out in the numbers. Until then, a rally that stalls under $750 reads as a pause in the decline, not a turn.
What to watch
- Earnings, November 4, 2026: the one item that matters is forward guidance, because the downgrade is about pricing and guidance is where management would show whether pricing is holding.
- Sector: XLK fell 7.1% in five days and 11.9% in a month, though it is still up 22.3% for the year. Moves in technology, and in the AI-linked names, have been shaping FICO before its own news arrives.
- Valuation: at $725.33 the shares trade 19.1% under the $897.05 mean price target, inside an analyst range of $490 to $1,230.97. The gap shows how much the Street expects the stock to recover, not that the price has stopped falling.